← All Strata Skin Sciences, INC filings

Strata Skin Sciences, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
SSKN
Strata Skin Sciences, INC
10-K/A: Strata Skin Sciences Files Amended 10-K to Include Part III Information
Strata Skin Sciences files an amendment to its 2024 annual report to include information required by Part III of Form 10-K, covering details about directors, executive compensation, and related matters.
OTC.Pink
SSKN
Strata Skin Sciences, INC
10-K: STRATA Skin Sciences Reports Losses in 2024, Navigates Supply Chain and Regulatory Challenges
STRATA Skin Sciences faced net losses in 2024 amid ongoing challenges including the Russia-Ukraine war's impact on gas supplies and evolving healthcare regulations.
OTC.Pink
SSKN
Strata Skin Sciences, INC
10-K/A: Strata Skin Sciences Files Amended 10-K Report, Details Executive Changes and Compensation
Strata Skin Sciences has filed an amendment to its annual report to include information required by Part III of Form 10-K, detailing changes in directors, executive compensation, and other corporate governance matters.
OTC.Pink
SSKN
Strata Skin Sciences, INC
10-K: Strata Skin Sciences Reports Full Year 2023 Results, Navigates Market Challenges
Strata Skin Sciences experienced a net loss of $10.8 million in 2023, while managing supply chain issues and transitioning its international sales model.